Devices & Neurotechnology
Details checkedStrong evidenceCheckedcompany

Rexton Reach Hearing Aids

Also known as: Rexton Reach, Reach R-Li T, Reach R Plus, Multi-Voice Focus

Rexton

Primary source
Company
Rexton
Program Type
Device
Modality
Hearing Aid/Software
Stage
Marketed
Status
Marketed
Target Gene
Route / Mode
External wearable prescription hearing aid platform
Confidence
87%
Status Confidence
Status confirmed
Evidence Strength
Strong evidence
Last Reviewed
2026-06-10
Geography
United States, Europe, Global
Population
adult, age-related, post-lingual
Trial IDs
0
Mechanism

Rechargeable prescription receiver-in-canal hearing-aid platform using Multi-Voice Focus technology to preserve multiple conversational voices in noisy environments.

Indications
Notes

Adds a major Costco-visible WS Audiology secondary brand and its current multi-speaker speech-in-noise positioning to the prescription hearing-aid layer.

Evidence & Sources
2 structured sources
company
Supports: canonicalName, aliases, company, programType, modality, mechanism, status, route
Open
company
Supports: allCompanies, notes, keyEvents
Open
Key Events
Related Programs